Lung-I Cheng

Vice President, Cell and Gene Therapy • AmerisourceBergen

Lung-I Cheng is Vice President, Cell and Gene Therapy, leading AmerisourceBergen’s Cell and Gene Therapy (CGT) service line within Commercial Solutions.

He is responsible for leading a unified CGT go-to-market strategy that addresses external customer needs, and provides integrated solutions that deliver the right resources at the right time to position therapies for success.

Before joining AmerisourceBergen, he spent a decade in biopharma and most recently led Takeda Oncology’s global value and access team in cell therapies and pipeline.

Also Speaking

David Hodl

Head of Sales, Cell Therapy Custom and Configured Platforms • Invetech

Peter Zandstra

Professor • University of British Columbia

Mark Sawicki

President & Chief Executive Officer • Cryoport Systems

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.